of IL-2 that induces 50% of maximal [3H]TdR incorporation by IL-2-dependent T cells in culture . The optimal concentration of rIL-2 as determined in the B cell proliferation assay using 1-d preactivated anti-IgM blasts was found to be within the range of 5 to 10 IU/ml. Highly purified rIL-4 (from L 929 cells; 1.2 x 10' U/mg) was a kind gift ofDr. Arai (DNAX, Palo Alto, CA) (36) . 1 U of IL-4 is defined as the amount of IL-4 required to cause halfmaximal stimulation of tritiated thymidine ([3H]TdR) uptake by 5 x 103/200 Al T cells, which were preactivated for 3 d with PHA and then extensively washed. Since preliminary experiments had determined that optimal proliferation of anti-IgM blasts was reached with a concentration ofpurified rIL-4 of500 U/ml, all preincubation experiments were performed with 500 U/ml of rIL-4 . A commercial preparation ofa LMW BCGF partially purified from the culture supernatants of PHA-stimulated PBL was obtained from Cellular Products, Inc. (Buffalo, NY) and will be referred to in the text as LMW BCGF.
Mitogens. Insolubilized rabbit anti-human IgM antibody was purchased from Bio-Rad Laboratories (Richmond, CA) . Formalinized SAC was purchased as Pansorbin from Calbiochem-Behring Corp. (La Jolla, CA).
Antibodies . The monoclonal and polyclonal antibodies used for phenotyping the B cell preparations were purchased from the following manufacturers : Becton-Dickinson Monoclonal Center (Mountain View, CA) : Leu 3 (CD4), Leu 5 b (CD2), Leu 7, Leu 11 (CD16), Leu 12 (CD19), Leu M3 (CD14) ; Ortho Pharmaceutical Corp. (Raritan, NJ) : OKT3 (CD3), OKT4 (CD4), OKT8 (CD8), OKT11(CD2); Coulter Immunology (Hialeah, FL) : BI (CD20), M01 (CDll) and M02 (CD14) ; Behring AG (Marburg, Federal Republic of Germany): F(ab')2 fragments anti-human Ig coupled to FITC; Grub (Vienna, Austria): FITC-conjugated F(ab')2 fragments of goat anti-mouse Ig used in the indirect immunofluorescence assays . The neutralizing rabbit anti-IL-4 serum was raised in our laboratory and was prepared as follows. Male rabbits were immunized subcutaneously and intramuscularly with 100 ug of Escherichia coli-derived rIL-4 in 1 ml CFA (Difco Laboratories, Detroit, MI). The animals were boosted twice with rIL-4 . Blood was collected 3 wk after the third immunization and the antiserum was isolated . The Ig fraction was purified on protein A columns (BioRad Laboratories) . This antiserum is specific for IL-4: it blocks IL-4-induced IgG/IgM production from SAC blasts (31) , IL-4-induced proliferation of T and B cells, and IL-4-induced CD23 expression on the Burkitt lymphoma cell line Jijoye (Chretien, I., A. van Kimmenade, M . K. Pearce, J. Banchereau, J. S. Abrams, submitted for publication) . The anti-IL-4 antiserum did not block the biological activities of IL-2 either on T cells (proliferation) or on B cells (proliferation and differentiation) . The biological activities of rIL-4 originating from different sources (L929 cells, CHO cells, and E. colt) were equally blocked by the anti-IL-4 antiserum . A neutralizing anti-IFN-'P serum raised in the laboratory was used as control .
B Cell Preparations, B cells were isolated from tonsils . Mononuclear cells were separated by standard Ficoll/Hypaque gradient method . B cells were obtained by twice rosetting with aminoethylisothiouronium (AET Sigma Chemical Co., St. Louis, MO)-treated S RBC . The B cell-enriched populations obtained were typically >95% surface Ig-positive, >957o BI (CD20) antigen-positive. Less than 1 % of the cells expressed the T cell markers CD2, CD3, CD4, and CD8, or the monocyte markers CD11 and CD14. Less than 1% of the cells reacted with the NK cell markers Leu 7 and Leu 11. Purified B cells were then further separated according to size using a discontinuous gradient of Percoll (Pharmacia Fine Chemicals, Uppsala, Sweden) consisting of four solutions (1.075, 1.070, 1 .060, and 1 .055 g/ml) sequentially layered on top of each other (3 ml of each solution in a 15-ml centrifuge tube, No. 2095; Falcon Labware, Oxnard, CA) . 5 x 10' purified B cells were laid on top of the gradient and centrifuged for 20 min at 550 g at 20'C. Resting B cells were recovered in the pellet, below the solution of Percoll of the highest density (p > 1.075 g/ml) .
Culture Conditions and Assays . Purified B cells were cultured in Iscove's medium enriched with 50 ug/ml human transferrin, 0.5 17o BSA, 5 ug/ml bovine insulin, oleic, linoleic, and palmitic acids (all from Sigma Chemical Co.), and 2% heat-inactivated FCS (Industrie Biologique Fran~aise, Genevilliers, France) as described by Yssel et al. (37) for proliferation assays. For differentiation assays, complete RPMI 1640 medium (Flow Laboratories, Irvine, CA) supplemented with selected heat-inactivated FCS, 2 mM glutamine, 100 U/ml penicillin, 100 Ng/ml streptomycin (all from Flow Laboratories), 50 wg/ml gentamicin (Laboratorres UNICET Levallois-Perret, France), and 2% Hepes was used.
Proliferation Assay. B lymphocytes adjusted at 2 x 106 cells/ml in enriched Iscove's medium described above were stimulated by insolubilized anti-IgM antibody (10 Rg/ml) for 24 h . After activation, B cell blasts were harvested and centrifuged over Ficoll/Hypaque gradient to remove nonviable cells and anti-IgM beads . They were then resuspended at 106 cells/ml in enriched Iscove's medium and dispensed under a volume of 50 A1 into wells of microtiter trays . Factors to be tested for their B cell growth-promoting activity were added to reach a final volume of 100 pl . Cells were pulsed with [ 3 H]TdR (1 pCi/well, sp act 25 Ci/mmol ; CEA, Saclay, France) during the last 16 h of the culture period . [ 3 H]TdR uptake was measured by standard liquid scintillation counting techniques after harvesting, using a scintillation counter (LKB Instruments, Bromma, Sweden). The proliferative response of B cell blasts was measured at different intervals from the beginning of culture (from day 2 to day 6) . In some experiments, B cell blasts generated after 1 d of preactivation with SAC (0 .05%) were also used.
Cell Cycle Analysis. The flow cytometric measurement of total DNA content was done using three different techniques : a single staining method with propidium iodide (PI), a single staining method using Hoechst 33 342 as described by Taylor (38) , and a double-staining method combining bromodeoxyuridine (BrdUrd), which is incorporated in place of thymidine in DNA during S phase of the cell cycle, and PI, which stains double-stranded DNA. This technique was performed according to Dolbeare et al . (39) , with some modifications as described previously (20) . DNA histograms, obtained after PI or Hoechst single staining, were analyzed using the mathematical model of Dean and Jett (40) . Each DNA histogram was built after acquisition of 2 x 104 cells . Differentiation Assay. High density tonsillar B cells (p > 1 .075 g/ml) at 2 x 10 6 cells/ml in complete RPMI 1640 medium (as described above) were stimulated for 2 d with SAC used at a final concentration of 0 .05% . To remove nonviable cells and SAC particles, activated B cells were centrifuged (15 min, 550 g) on a gradient consisting of two overlaid solutions of Percoll with densities of 1 .077 g/ml and 1 .055 g/ml. Viable B cell blasts were recovered at the interface between the two solutions . B cell blasts resuspended in complete RPMI medium were then dispensed (10 5 cells/well) into wells of flat-bottomed microtiter trays (Falcon Labware) . Factors to be tested were added in appropriate volumes to reach a final culture volume of 200 ul per well . Each culture point was performed in quadruplicate . Supernatants were harvested 4 d after the onset of the second culture and were kept at -20'C until Ig levels were determined by ELISA. In some experiments, SAC-activated B cell blasts were further separated into CD25' (Tac') and CD25 -(Tac-) populations with the FAGS after indirect immunofluorescence staining using an anti-CD25 mAb (BI 49 .9 mAb ; Immunotech, Marseille Luminy, France) and FITC-conjugated F(ab')2 fragments of goat anti-mouse Igs (Grub). The two populations were assayed for proliferation and differentiation using the culture conditions described above .
Assay of Ig Production . The cumulative total Ig in the culture was determined by double sandwich ELISA as described by Voller (41) . Briefly, microtiter plates (Immunoplates ; Nunc, Roskilde, Denmark) were coated with 200 wl of appropriate dilutions of specific anti-IgG, anti-IgM (Behring AG, Marburg, Federal Republic of Germany) or anti-IgA (Biosys, Compiegne, France) in pH 9 .6 carbonate buffer overnight at 4'C . After washing, 200-w1 serial dilutions of IgG, IgA, and IgM standards (Behring) in PBS Tween 0 .05% were added to the respective plates as calibration curves . Dilutions of culture supernatants were added at the same time . After 2 h at room temperature, the plates were washed, and 200 ul of diluted specific alkaline phosphatase-conjugated anti-IgG, anti-IgM (Behring), or anti-IgA (Biosys) was added . After 2 h at room temperature, plates were washed and 200 pl p-nitrophenylphosphate (Sigma Chemical Co.) in diethanolamine buffer was added . Plates were incubated at 37 0 C, and OD were measured at 405 nm by using an Autoreader (MR 580 ; Dynatech Laboratories, Inc ., Alexandria, VA) . OD data were collected and were processed with an Apple IIe computer. Concentrations of Ig in culture supernatants were expressed as nanograms per milliliter.
Preculture Experiments . B cell blasts (generated after 24 h of stimulation with insolubilized anti-IgM or SAC) or high density resting B cells were cultured for 24 h at a cell density of 2 x 10 6 cells/ml in complete RPMI 1640 medium alone or with rIL-4 (500 U/ml) . After preculturing, B cells were centrifuged (15 min, 550 g) on a Percoll solution of 1 .055 g/ml .
Viable cells recovered in the pellet were then washed and tested for their capacity to proliferate in response to different factors . When resting B cells were used for preculture experiments, the factors to be tested in the second culture period were used in costimulation with insolubilized anti-IgM antibody (at a final concentration of 10 jig/ml) . The proliferative response was routinely measured 3 (34, 35) , we studied the proliferation of activated B cells in response to combinations of rIL-4 and rIL-2. For this purpose, a two-step assay was performed. Highly purified tonsillar B cells were first preactivated for 24 h with insolubilized anti-IgM antibody (10 wg/ml) or SAC, then recultured for an additional period of 3 d with either purified rIL-4, purified rIL-2, or with a combination of both lymphokines. B cell proliferation was monitored by [3H]TdR uptake. As illustrated in Table I , at optimal concentration ofboth lymphokines (10 U/ml for rIL-2; 500 U/ml for rIL-4) the levels of [3H]TdR incorporation obtained with rIL-2 were significantly higher than those obtained with rIL-4. Surprisingly, when preactivated B cells were cocultured with rIL-4 and rIL-2, B cell proliferation was lower than that observed with rIL-2 alone and was in most cases comparable to the levels of proliferation obtained with rIL-4 alone (Exps. 1, 2, 4, 5, Table I ). In some experiments (Exps. 3 and 6, Table I ), addition of rIL-4 to rIL-2-stimulated cultures did not reduce the levels of [3H]TdR uptake to these obtained with rIL-4 alone, although the proliferative response to rIL-2 was significantly inhibited . It is also shown (Table I, Exp. 6) that relatively low amounts of rIL-4 (20 U/ml) can significantly reduce the growth-promoting effect of rIL-2, and that the inhibitory effect of rIL-4 on rIL-2-mediated proliferation is also observed when SAC is used instead of antiIgM antibody for preactivation ofB cells. In some experiments, (one of five, approximately) the proliferation in response to rIL-4 was higher than the proliferation TABLE I rIL-4 Inhibits the rIL-2-mediated Proliferation of Preactivated B Cells Exps . 1-5 were performed on anti-IgM blasts recovered after 1 d of preactivation . Exp . 6 was performed on SAC blasts recovered after 1 d of preactivation . Each value represents the mean t SD of triplicate determinations . rIL-2 was used at the final concentration of 10 U/ml . rIL-4 was used at the final concentration of 500 U/ml (Exp . 1-4) ; 100 U/ml (Exp . 5) and 20 U/ml (Exp . 6) . obtained in response to rIL-2, and the proliferative response to the combination of rIL-2 and rIL-4 was equal to that obtained in response to rIL-4 (not shown here).
The cell cycle studies performed using the double-staining BrdUrd/PI, or the singlestaining systems (PI or Hoechst 33 342) confirmed the [3H]TdR uptake data . B cell blasts generated after 2 d of preactivation with SAC were recultured for 3 d with rIL-2 (10 U/ml), rIL-4 (500 U/ml), or rIL-2 + rIL-4. To prevent cycling cells from returning to Go/Gt, colcemid (0 .1 wg/ml) was added during the last 24 h of the culture . Data displayed in Table II show that rIL-4 significantly reduces the number of cells entering into cycle in response to rIL-2. The inhibition of the rIL-2-mediated B cell proliferation was a function of the concentration of rIL-4 used in the assay (Fig . 1) . Kinetics experiments (Fig . 2) demonstrated that the inhibitory effect of rIL-4 was not simply due to a delayed proliferative response to rIL-2, since inhibition could be observed from day 3 up to day 6 after the onset of the culture. When [3H]TdR uptake was measured at earlier time points (12, 24 , and 48 h), it was consistently observed that the peak of [3H]TdR uptake in response to rIL-2 was not precipitated in the presence of rIL-4 and that rIL-4 could inhibit the growth promoting effect of rIL-2 as early as 24 h after the onset of the culture (data not shown) . To rule out the possibility that the antagonizing activity of IL-4 could be mediated via a non-B cell population, phenotypic analysis were performed on SAC blasts that were recultured for 2 additional d with rIL-2 (10 U/ml), rIL-4 (500 U/ml) or rIL-2 plus rIL-4. As illustrated in Fig. 3 , immunofluorescence stainings performed with anti-CD2 and anti-CD20 mAbs established that these three cell populations were composed of >95% B cells, whereas T cells remained under detection levels . Taken together these data indicate that IL-4 can at least partially inhibit the proliferative response of activated B cells to IL-2 and suggest that the antagonizing effect of IL-4 is exerted directly on B cells.
Effect ofPreculture with rIL-4 on the Subsequent Proliferative Response of B Cells to rIL-2.
To further explore the inhibitory mechanism of IL-4 on IL-2-induced B cell proliferation, experiments were designed in which B cells were first preincubated with rIL-4 for 24 h before culturing with rIL-2. In the first set of experiments, B cell blasts ISO ated after 48 h of activation with SAC were recultured for 48 h with rIL-4 (500 U/ml), rIL-2 (10 U/ml), or rIL-4 plus rIL-2 and stained with a FITC conjugated panT cell marker (anti-CD2 mAb) or a FITC conjugated pan-B cell marker (anti-CD20 mAb) . The negative control was performed with a nonrelated mAb of the same isotype. 1 
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The right limit of the histogram obtained with the negative control is figured by a vertical line . Abscissa fluorescence intensity (log scale) . Ordinate relative cell number. (Fig . 5 B) . This was observed as well for the control samples that had been pretreated with medium during the first culture period Preculture of resting B cells with rIL-4 does not alter their capacity to proliferate in response to rIL-2 plus antiIgM. RestingB cells recovered in the high density fraction (p > 1 .075 g/ml) after centrifugation on Percoll gradients were first incubated with medium (EI) or rIL-4 (500 U/ml), (*) for 24 h. Viable cells were then recovered and assayed for proliferation in (data not shown) . These data suggest that IL-4 can affect the capacity of B cells to proliferate in response to IL-2 only when these cells have received an activation signal in vitro.
rIL-4 Does Not Inhibit rIL-2-induced B Cell Differentiation. Since IL-4 can drive activated B cells to differentiate and produce IgG and IgM (31), we next studied whether IL-4 inhibited the IL-2-mediated proliferation of activated B cells by enhancing their differentiation . To test this hypothesis, B cell blasts generated from high density tonsillar B cells after 2 d of activation with SAC were recultured with rIL-4, rIL-2, or the combination of both lymphokines at optimal and suboptimal concentrations . B cell differentiation was monitored by measurement of Ig content (IgG, IgA, and IgM) in the culture supernatants 4 d after the onset of culture. Data illustrated in Table III show that, whatever the concentration of rIL-4 used in combination with rIL-2, no inhibition of rIL-2-mediated IgG production is observed . At optimal con- 
centration of rIL-2 (10 U/ml), rIL-2-induced IgG production is not affected by rIL-4, whereas at suboptimal concentrations of rIL-2 (0 .3 and 1.25 U/ml), the effects of rIL-4 and rIL-2 on IgG production are roughly additive . Similar results were obtained with the production of IgM (data not shown) . It is noteworthy that rIL-2-mediated IgA production is not suppressed by rIL-4, which by itself induces only a very weak IgA production . To further explore the apparently contradictory effects of IL-4 on IL-2-mediated proliferation and IL-2-mediated differentiation, B cell blasts recovered after 2 d of preactivation with SAC were sorted according to the expression of CD25 . CD25' and CD25 -B cells were then assayed for proliferation and differentiation in response to optimal concentrations of rIL-4, rIL-2, or rIL-2 plus rIL-4. Data illustrated in Table IV demonstrate that the CD25 + population proliferates and differentiates in response to both rIL-2 and rIL-4. In addition, rIL-4 was found to inhibit the proliferation of CD25+ B cells in response to rIL-2 without affecting rIL-2-induced differentiation. The CD25 -B cells did not proliferate nor did they differentiate in response to rIL-4, rIL-2, or to the combination of both lymphokines (data not shown) . Taken Proliferation of CD25`blasts was determined after 72 h of culture, and IgM production was evaluated after 96 h of culture . ' Purified rIL-2 was used at 10 U/ml . $ Purified rIL-4 was used at 500 U/ml . antiserum. In the absence of antibody the [3H]TdR uptake in cultures of anti-IgM blasts stimulated with rIL-4, rIL-2, or rIL-2 plus rIL-4 were, respectively : 44 ± 4.0 x 10 3 cpm, 106 t 4.0 x 10 3 cpm, and 62 t 2.0 x 10 3 cpm. When anti-IL-4 antiserum is added at the onset of the culture or 7 h after the onset of the culture, the inhibitory effect of rIL-4 is totally blocked (levels of [3H]TdR uptake being respectively, 90 and 98% of the level of [3H]TdR uptake induced by rIL-2 alone) . After 24 h of culture, addition of anti-IL-4 antiserum no longer blocks the inhibitory effect of rIL-4. The presence of the control antiserum did not affect rIL-4-mediated inhibition of rIL-2-dependent B cell proliferation, whatever the time of its addition . These data demonstrate that the inhibition observed with rIL-4 is not due to contaminants and that rIL-4 needs to be present for more than 24 h to fully deliver its antagonizing effect .
Discussion
In this report, we have studied the proliferation and differentiation of preactivated tonsillar human B cells in response to combinations of purified rIL-2 and rIL-4. With the majority of the tonsillar B cell preparations, it was found that the maximal proliferative response was higher with rIL-2 than with rIL-4 provided that these factors were both used at optimal concentration. It was repeatedly observed that combinations of rIL-2 and rIL-4 resulted in proliferation that was lower than that observed with rIL-2 alone and often equivalent to that observed with rIL-4. rIL-4 reduced the levels of [3H]TdR uptake (Table 1) induced by rIL-2 as well as the number of cells cycling in response to rIL-2 (Table II) . The antagonizing effect of rIL-4 was a function of its concentration, and relatively low amounts of rIL-4 (12 .5 U/ml) were sufficient to provide nearly maximum inhibition . Two lines of evidence demonstrated that the inhibitory effects of rIL-4 could not be due to contaminants : first, highly purified rIL-4 was used in all the experiments; second, the inhibitory effect of rIL-4 could be totally reversed by a neutralizing polyclonal anti-IL-4 antiserum. The inhibitory effect of rIL-4 was not due to a delayed response to rIL-2, since the inhibition of [3H]TdR incorporation was observed from day 3 to 6. As shown by phenotypic analysis with anti-CD2 and anti-CD20 mAbs, the cell populations cultured with rIL-2, rIL-4, or rIL-4 plus rIL-2 were composed of >95% B cells, whereas T cells and monocytes remained below the levels of detection. Therefore, it is unlikely that the growth inhibitory effect of IL-4 could be mediated via a non-B cell population .
Treatment of anti-IgM as well as SAC preactivated B cells with rIL-4 for 24 h significantly reduced their subsequent proliferation in response to rIL-2. Delayed addition of the neutralizing anti-IL-4 antiserum to anti-IgM blasts cultured with rIL-4 and rIL-2 established that the inhibitory effect of rIL-4 on rIL-2-induced proliferation required cells to be in contact with rIL-4 for at least 24 h. This also corresponds to the minimum length of time necessary for rIL-4 to display B cell growth factor activity (20) . In contrast, resting B cells pretreated with rIL-4 were still able to fully respond to the growth-promoting activity of rIL-2 in combination with antiIgM antibody. Nevertheless, readdition of rIL-4 together with rIL-2 and anti-IgM antibody in the second culture period could still block the rIL-2-mediated proliferative response of these cells. These findings suggest that in vitro activation of B cells with anti-IgM antibody or SAC before treatment with rIL-4 or together with rIL-4 is necessary for development of the inhibitory effect of rIL-4.
Experiments performed on SAC blasts demonstrated that rIL-4 did not suppress rIL-2-induced Ig synthesis. rIL-4 did not significantly potentiate Ig production induced by rIL-2 (used at optimal concentration), therefore suggesting that the antagonistic activity of rIL-4 on B cell proliferation induced by IL-2 was not due to an enhancing effect of rIL-4 on rIL-2-mediated differentiation . However, the possibility remained that the apparently unchanged levels of Ig production detected in the rIL-2 plus rIL-4-stimulated cultures compared with the rIL-2-stimulated cultures was in fact reflecting the sum of rIL-4-induced Ig secretion and reduced rIL-2-mediated Ig secretion. This hypothesis was ruled out by the IgA results (Table III) , which demonstrate that rIL-4 (which does not induce significant production of IgA by itself) does not suppress rIL-2-mediated IgA production .
In view of the fact that IL-4 can cooperate with IFN-y and LMW BCGF for B cell proliferation (20) and with IL-2 for T cell proliferation (22) , the counteracting effect of IL-4 on the B cell growth-promoting activity of IL-2 was an unexpected finding. However, there is now growing evidence that IL-4 can deliver negative signals to various cell types. Indeed, it has been demonstrated that IL-4 suppresses the generation of LAK cells from PBL by IL-2 (42, 43) . Moreover, IL-4 has been shown to inhibit the factor-dependent growth of pre-B cells from bone marrow precursors (44) . In addition, our finding that IL-4 antagonizes IL-2-dependent growth of activated normal B cells is in line with the recent data obtained with chronic lymphocytic leukemia B cells (B-CLL), whose IL-2-dependent proliferation is totally blocked by IL-4 (45) . Our data thus indicate that the IL-4-mediated inhibition of IL-2-dependent growth of B-CLL cells is not merely due to the transformed state of these cells. This suggests that B-CLL cells might represent the malignant counterpart of the normal B cell subset sensitive to the antagonizing activity of IL-4 .
The contrasting effects of IL-4 on IL-2-mediated proliferation and differentiation of preactivated human B cells suggest that these two IL-2-dependent events may be dissociated . Whether this dissociation is linked to the existence of two different B cell subsets, one differentiating and one proliferating in response to IL-2, remains to be determined . However, in line with this hypothesis, there are now reports that tend to support the notion that activated B cells can be separated according to their capacity to proliferate or differentiate in response to T cell factors. It has been shown that the B cell subset that proliferates in response to SAC is different from that which differentiates in response to SAC and irradiated T cells, and that these two populations can be separated by their ability or inability to form rosettes with mouse erythrocytes (46) . Moreover, Nakagawa et al. (47) recently demonstrated that SAC-activated B cell blasts can be divided into subsets that either differentiate or proliferate in response to IL-2 . It is thus tempting to speculate that the subpopulation proliferating in response to IL-2 is the target of the IL-4 inhibitory effects, whereas the subpopulation differentiating in response to IL-2 is not affected by IL-4 . It is likely that the B cell subpopulations differentiating in response to IL-2 and IL-4 may largely overlap, since the differentiative activities of both lymphokines used at optimal concentration are not additive, whereas they are roughly additive at suboptimal concentrations . In a first attempt to separate IL-2-and IL-4-responsive populations, we sorted out CD25+ and CD25 -B cells from a total population of SAC-activated blasts . It was found that B cells that did not express CD25 could not proliferate or differentiate in response to rIL-2 or rIL-4. Thus, cells proliferating and differentiating in response to rIL-2 or rIL-4 were included within the CD25 + subset . These experiments also confirmed, at the level of a B cell subpopulation selected on the expression of the IL-2 receptor, that rIL-4 can antagonize rIL-2-mediated B cell growth without affecting rIL-2-induced Ig production . Presently, we can only speculate on the nature of the mechanism involved in the inhibitory activity of IL-4 . An IL-4-mediated downregulation of the expression of the IL-2 receptor heterodimer could be a possible explanation. Binding experiments are presently being performed to challenge this hypothesis .
The data presented in this report demonstrate that, in addition to its stimulatory effects on the immune response, IL-4 delivers inhibitory signals to B cells. This finding adds further complexity to the understanding of the sequence of events that affect a B cell once it has encountered its specific antigen.
Summary
The combined effect of IL-4 and IL-2 on proliferation of anti-IgM antibody or Staphylococcus aureus strain Cowan I (SAC)-preactivated B cells was investigated. It was observed that in most cases, rIL-2 used at optimal concentration induced higher levels of tritiated thymidine ([3H]TdR) uptake than rIL-4 used at optimal concen-tration . When rIL-4 and rIL-2 were added together, it was repeatedly found that B cell proliferation induced by rIL-2 was significantly reduced and was, in most cases, comparable with the proliferation induced by rIL-4 alone . Cell cycle studies demonstrated that rIL-4 significantly reduced the number of cells entering S and G2/M phases of the cell cycle upon rIL-2 stimulation . B cell blasts preincubated for 24 or 48 h with rIL-4 displayed a reduced proliferation in response to rIL-2. In contrast, preculture of resting B cells with rIL-4 did not impair their subsequent proliferation in response to rIL-2 plus insolubilized anti-IgM antibody. This suggests that rIL-4 can only exert its inhibitory effect once B cells have received an activation signal . The differentiative activity of rIL-2 measured on B cell blasts preactivated for 2 d with SAC was not altered by rIL-4, which suggests that rIL-4 did not exert its inhibitory activity on rIL-2-induced B cell proliferation by enhancing rIL-2-mediated differentiation . Delayed addition of a neutralizing anti-IL-4 antiserum demonstrated that a period of contact of at least 24 h between IL-4 and B cell blasts was necessary for the development of the antagonistic effect of IL-4 on IL-2-mediated growth of activated B cells . These data demonstrate that IL-4 antagonizes the B cell growth-promoting effect of IL-2 without affecting the differentiation of preactivated B cells in response to IL-2.
